Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Autologous Adipose-Derived Stem/Stromal Cells In Symptomatic Benign Prostate Hypertrophy

NCT02961114 is registered in ClinicalTrials.gov with Robert W. Alexander, MD, FICS as lead sponsor.

NCT NCT02961114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02961114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Autologous Adipose-Derived Stem/Stromal Cells In Symptomatic Benign Prostate Hypertrophy
Lead sponsor
Robert W. Alexander, MD, FICS
Phase
Phase 1/2
Overall status
Withdrawn
Start date
November 1, 2019
Completion date
July 31, 2023
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bph, bph with urinary obstruction, nocturia, prostate inflammation, prostatism